Find-Speaker.com




4th annual Biosimilars North America (description)

""

Category:Pharmacology
Address:Renaissance Woodbridge Hotel, 515 US-1 Iselin, New Jersey, United States of America 08830
Phone:+44(0)2078276102
Event dates:11/15/2017 - 11/16/2017 (This event has already taken place)
Event web site:http://go.evvnt.com/130541-0
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 4th annual Biosimilars North America

Speakers/Presenters:

Topics to be Covered:

Contact:hdegracia@smi-online.co.uk
Organizer phone:+44(0)2078276102
Offering type:Conference
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:SMi Group
Est. # of exhibitors:
Currency:US Dollars
Language:English
CE Credits:
Organizer URL

Description:

The first biosimilar product launched in the US in 2015. Currently there are only 4 biosimilar products approved but the North Americas market continues to grow and has become highly lucrative. As such, pharmaceutical companies continue to find ways to differentiate their products in such a saturated market. Thus, Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development, and ensure optimal market access and commercialization opportunities whilst complying with evolving regulatory requirements.

This year, the conference will also explore significant developmental topics within the sector including the impact of FDA’s newly implemented biosimilar interchangeability guidelines, the US market access landscape, and biosimilars of orphan drugs.

Key highlights include
- A presentation from Sandoz on the FDA issuing the long-awaited biosimilar interchangeability guidance
- A session on complex biosimilars and new technologies from MedImmune
- Momenta Pharmaceuticals will provide strategies to combat legal, policy and commercial obstacles to development and launch.
- Insights on latest development strategies and market access from Fujifilm Diosynth Biotechnologies
- A talk on drug product and formulation development considerations with Oncobiologics
Key speakers include
- Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals Inc
- Cindy Cao, Executive Director & Head of US Regulatory Affairs fo Biopharmaceuticals, Sandoz
- T. Shantha Raju, Senior Director, MedImmune
- Chrys Kokino, Head Global Biologics Commercial, Mylan
- Steinar Madsen, Medical Director, Norwegian Medicines Agency
- Bruce Leicher, Senior Vice President and General Counsel, Momenta Pharmaceuticals
- Hiten Gutka, Principal Scientist Formulation Development - Biosimilar Development, Oncobiologics Inc
- Patrick Robertson, Director, Program Design, FUJIFIlM Diosynth Biotechnologies

Schedule:

Time: 8:30 am to 5:30 pm

Registration Fee Details:

Book by June 30: USD 1599
Book by September 29: USD 1799
Standard: USD 1899
Workshop: USD 499

Other items that tuition includes:

Travel and hotel arrangements:

 
 
Contact Person:Honey de Gracia
Contact Emailhdegracia@smi-online.co.uk
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Organizer Phone+44(0)2078276102
Structural makeupData not provided
Host Sponsor; Other SponsorsSMi Group
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Range:
Number in attendance of:
Range:
Target BoundariesInternational
Is Registration contact information the same as Organizer Contact above?Yes
Web Page https://go.evvnt.com/130541-1
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?NA
Online housing reservations: 
 
Do you have additional written or AV materials for sale?NA
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?NA
Will there be shuttle service available?NA

Sign In/Sign Out
About Us
FAQ
Contact Us